A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers

키워드

참고문헌 (85)

1. "Infection with Helicobacter pylori", IARC Monogr Eval Carcinog Risks Hum, 61, pp.177~240 (1994)
2. Torres J, "Trends in Helicobacter pylori infection and gastric cancer in Mexico", Cancer Epidemiol Biomarkers Prev, 14, pp.1874~1877 (2005)
3. Kuipers EJ, "The prevalence of Helicobacter pylori in peptic ulcer disease", Aliment Pharmacol Ther, 9(Suppl 2), pp.59~69 (1995)
4. Lee YC, "The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention", Gut, 62, pp.676~682 (2013)
5. Helicobacter pylori eradication as a strategy for gastric cancer prevention, "IARC Helicobacter pylori Working Group", International Agency for Research on Cancer, ~, pp.IARC Working Group Reports, No. 8 (2015)
6. Xia B, "Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong", Aliment Pharmacol Ther, 22, pp.243~249 (2005)
7. Uyub AM, "Helicobacter pylori infection in north-eastern peninsular Malaysia:evidence for an unusually low prevalence", Scand J Gastroenterol, 29, pp.209~213 (1994)
8. Sugiyama T, "Attributable risk of H. pylori in peptic ulcer disease: does declining prevalence of infection in general population explain increasing frequency of non-H. pylori ulcers?", Dig Dis Sci, 46, pp.307~310 (2001)
9. Singh V, "Epidemiology of Helicobacter pylori and peptic ulcer in India", J Gastroenterol Hepatol, 17, pp.659~665 (2002)
10. Asaka M, "Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population", Gastroenterology, 102, pp.760~766 (1992)
11. Musumba C, "The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease:observations from a tertiary referral hospital in the UK between 2005 and 2010", Aliment Pharmacol Ther, 36, pp.48~56 (2010)
12. Graham DY., "Large U.S. clinical trials report a high proportion of H. pylori negative duodenal ulcers at study entry as well as a high recurrence rate after cure of the infection: have we all been wrong?", Gastroenterology, 114(Suppl 1), pp.A17~ (1998)
13. Nensey YM, "Helicobacter pylori-negative duodenal ulcer", Am J Med, 91, pp.15~18 (1991)
14. Sprung DJ, "What is the role of Helicobacter pylori in peptic ulcer and gastric cancer outside the big cities?", J Clin Gastroenterol, 26, pp.60~63 (1998)
15. Jyotheeswaran S, "Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?", Am J Gastroenterol, 93, pp.574~578 (1998)
16. Charpignon C, "Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin", NSAID intake, 2013, pp.38, 946~954
17. Borody TJ, "Helicobacter pylori-negative duodenal ulcer", Am J Gastroenterol, 86, pp.1154~1157 (1991)
18. Higuchi K, "Is Helicobacter pylori-negative duodenal ulcer masked by the high prevalence of H. pylori infection in the general population?", Am J Gastroenterol, 94, pp.3083~3084 (1999)
19. Tsuji H, "Helicobacter pylori-negative gastric and duodenal ulcers", J Gastroenterol, 34, pp.455~460 (1999)
20. Arakawa T1, "Helicobacter pylori: criminal or innocent bystander?", J Gastroenterol, 35(Suppl 12), pp.42~46 (2000)
21. Aoyama N, "Helicobacter pylori-negative peptic ulcer in Japan: which contributes most to peptic ulcer development, Helicobacter pylori, NSAIDS or stress?", J Gastroenterol, 35(Suppl 12), pp.33~37 (2000)
22. Nishikawa K, "Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population", Eur J Gastroenterol Hepatol, 12, pp.635~640 (2000)
23. Chan HL, "Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients", Gastrointest Endosc, 53, pp.438~442 (2001)
24. Kamada T, "Significance of an exaggerated meal-stimulated gastrin response in pathogenesis of Helicobacter pylori-negative duodenal ulcer", Dig Dis Sci, 48, pp.644~651 (2003)
25. Chu KM, "Patients with Helicobacter pylori positive and negative duodenal ulcers have distinct clinical characteristics", World J Gastroenterol, 11, pp.3518~3522 (2005)
26. Hung LC, "Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study", Gastroenterology, 128, pp.1845~1850 (2005)
27. Ong TZ, "Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study", J Clin Gastroenterol, 40, pp.795~800 (2006)
28. Jang HJ, "Has peptic ulcer disease changed during the past ten years in Korea? A prospective multi-center study", Dig Dis Sci, 53, pp.1527~1531 (2008)
29. Chen TS, "Prevalence of Helicobacter pylori infection in duodenal ulcer and gastro-duodenal ulcer diseases in Taiwan", J Gastroenterol Hepatol, 25, pp.919~922 (2010)
30. Wong GL, "Gastroprotective therapy does not improve outcomes of patients with Helicobacter pylori-negative idiopathic bleeding ulcers", Clin Gastroenterol Hepatol, 10, pp.1124~1129 (2012)
31. 김진주, "2007년도 3차기관에서 진단된 소화성궤양 환자의 임상상", 대한소화기학회지, 59(5), pp.338~346 (2012), 대한소화기학회[DOI]
32. Ciociola AA, "Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated", Am J Gastroenterol, 94, pp.1834~1840 (1999)
33. Gisbert JP, "H. pylori-negative duodenal ulcer prevalence and causes in 774 patients", Dig Dis Sci, 44, pp.2295~2302 (1999)
34. Meucci G, "Prevalence and risk factors of Helicobacter pylori-negative peptic ulcer: a multicenter study", J Clin Gastroenterol, 31, pp.42~47 (2000)
35. Arents NL, "Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8 year period", Eur J Gastroenterol Hepatol, 16, pp.779~783 (2004)
36. Sbrozzi-Vanni A, "Low prevalence of idiopathic peptic ulcer disease: an Italian endoscopic survey", Dig Liver Dis, 42, pp.773~776 (2010)
37. Vu C, "Prevalence of Helicobacter pylori in peptic ulcer disease in a Singapore hospital", Singapore Med J, 41, pp.478~481 (2000)
38. Yakoob J, "Prevalence of non-Helicobacter pylori duodenal ulcer in Karachi, Pakistan", World J Gastroenterol, 11, pp.3562~3565 (2005)
39. Ootani H, "Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan", J Gastroenterol, 41, pp.41~46 (2006)
40. Goenka MK, "Helicobacter pylori negative, non-steroidal anti-inflammatory drug-negative peptic ulcers in India", Indian J Gastroenterol, 30, pp.33~37 (2011)
41. Kang JM, "Analysis of direct medical care costs of peptic ulcer disease in a Korean tertiary medical center", Scand J Gastroenterol, 47, pp.36~42 (2012)
42. Uyanikoglu A, "Etiological factors of duodenal and gastric ulcers", Turk J Gastroenterol, 23, pp.99~103 (2012)
43. 윤혁, "High Recurrence Rate of Idiopathic Peptic Ulcers in Long-Term Follow-up", Gut and Liver, 7(2), pp.175~181 (2013), 거트앤리버 발행위원회
44. Chow DK, "Non-NSAID non-H. pylori ulcer disease", Best Pract Res Clin Gastroenterol, 23, pp.3~9 (2009)
45. Quan C, "Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs", Am J Gastroenterol, 97, pp.2950~2961 (2002)
46. Gisbert JP, "Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis", Am J Gastroenterol, 101, pp.848~863 (2006)
47. Raj SM, "Further evidence for an exceptionally low prevalence of Helicobacter pylori infection among peptic ulcer patients in north-eastern peninsular Malaysia", Trans R Soc Trop Med Hyg, 95, pp.24~27 (2001)
48. Laine L, "Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori", Ann Intern Med, 129, pp.547~550 (1998)
49. Chey WD, "Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism", Am J Gastroenterol, 92, pp.446~450 (1997)
50. Lee JM, "Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding", Am J Gastroenterol, 95, pp.1166~1170 (2000)
51. Lee TH, "Increasing biopsy number and sampling from gastric body improve the sensitivity of rapid urease test in patients with peptic ulcer bleeding", Dig Dis Sci, 60, pp.454~457 (2015)
52. Leung WK, "False-negative biopsy urease test in bleeding ulcers caused by the buffering effects of blood", Am J Gastroenterol, 93, pp.1914~1918 (1998)
53. Bayerdorffer E, "Topographic association between active gastritis and Campylobacter pylori colonisation", J Clin Pathol, 42, pp.834~839 (1989)
54. Genta RM, "Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution", Gastrointest Endosc, 40, pp.342~345 (1994)
55. Craanen ME, "Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum", Gut, 33, pp.16~20 (1992)
56. Hirschowitz BI, "Intractable upper gastrointestinal ulceration due to aspirin in patients who have undergone surgery for peptic ulcer", Gastroenterology, 114, pp.883~892 (1998)
57. Lanas A, "Evidence of aspirin use in both upper and lower gastrointestinal perforation", Gastroenterology, 112, pp.683~689 (1997)
58. Blank MA, "Nonclinical model for assessing gastric effects of bisphosphonates", Dig Dis Sci, 42, pp.281~288 (1997)
59. Graham DY, "Alendronate gastric ulcers", Aliment Pharmacol Ther, 13, pp.515~519 (1999)
60. Pruitt RE, "Endoscopy, gastric ulcer, and gastric cancer: follow-up endoscopy for all gastric ulcers?", Dig Dis Sci, 38, pp.284~288 (1993)
61. Podolsky I, "Gastric adenocarcinoma masquerading endoscopically as benign gastric ulcer: a five-year experience", Dig Dis Sci, 33, pp.1057~1063 (1988)
62. Saini SD, "Utilization of upper endoscopy for surveillance of gastric ulcers in the United States", Am J Gastroenterol, 103, pp.1920~1925 (2008)
63. Breslin NP, "Survey of current practices among members of CAG in the follow-up of patients diagnosed with gastric ulcer", Can J Gastroenterol, 13, pp.489~493 (1999)
64. Kaltenbach T, "American Gastroenterological Association. American Gastroenterological Association (AGA) Institute technology assessment on image-enhanced endoscopy", Gastroenterology, 134, pp.327~340 (2008)
65. Goh KL., "Prevalence of and risk factors for Helicobacter pylori infection in a multi-racial dyspeptic Malaysian population undergoing endoscopy", J Gastroenterol Hepatol, 12, pp.S29~S35 (1997)
66. Niv Y, "Membrane-bound mucins and mucin terminal glycans expression in idiopathic or Helicobacter pylori, NSAID associated peptic ulcers", World J Gastroenterol, 20, pp.14913~14920 (2014)
67. Niv Y, "Secreted and membrane-bound mucins and idiopathic peptic ulcer disease", Digestion, 86, pp.258~263 (2012)
68. Azuma T, "Genetic differences between duodenal ulcer patients who were positive or negative for Helicobacter pylori", J Clin Gastroenterol, 21(Suppl 1), pp.S151~S154 (1995)
69. Xia HH, "Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study", Aliment Pharmacol Ther, 15, pp.1875~1882 (2001)
70. Cryer B, "Effect of aging on gastric and duodenal mucosal prostaglandin concentrations in humans", Gastroenterology, 102(4 Pt 1), pp.1118~1123 (1992)
71. Lee YC, "The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease", Gut, 58, pp.174~181 (2009)
72. Ma L, "Effects of cigarette smoking on gastric ulcer formation and healing: possible mechanisms of action", J Clin Gastroenterol, 27(Suppl 1), pp.S80~S86 (1998)
73. Luo JC, "Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study", Aliment Pharmacol Ther, 36, pp.542~550 (2012)
74. Kanno T, "Hemorrhagic ulcers after Great East Japan Earthquake and Tsunami: features of post-disaster hemorrhagic ulcers", Digestion, 87, pp.40~46 (2013)
75. Kanno T, "Peptic ulcers after the Great East Japan earthquake and tsunami: possible existence of psychosocial stress ulcers in humans", J Gastroenterol, 48, pp.483~490 (2013)
76. Levenstein S, "Psychological stress increases risk for peptic ulcer, regardless of Helicobacter pylori infection or use of nonsteroidal anti-inflammatory drugs", Clin Gastroenterol Hepatol, 13, pp.498.e1~506.e1 (2015)
77. Freston JW., "Review article: role of proton pump inhibitors in non-H. pylori-related ulcers", Aliment Pharmacol Ther, 15(Suppl 2), pp.2~5 (2001)
78. Freston JW., "Helicobacter pylori-negative peptic ulcers : frequency and implications for management", J Gastroenterol, 35(Suppl 12), pp.29~32 (2000)
79. Howden CW, "Current indications for acid suppressants in Helicobacter pylori-negative ulcer disease", Best Pract Res Clin Gastroenterol, 15, pp.401~412 (2001)
80. McColl KE., "Helicobacter pylori-negative ulcer disease", J Gastroenterol, 35(Suppl 12), pp.47~50 (2000)
81. Bytzer P, "Danish Ulcer Study Group. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis: results from a randomized trial with 2-year follow-up", Am J Gastroenterol, 96, pp.1409~1416 (2001)
82. Hyvarinen H, "Helicobacter pylori-negative duodenal and pyloric ulcer: role of NSAIDs", Digestion, 57, pp.305~309 (1996)
83. McColl KE, "A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration", Gut, 34, pp.762~768 (1993)
84. Wong GL, "High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers", Gastroenterology, 137, pp.525~531 (2009)
85. Gillen D, "Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole", Gut, 44, pp.468~475 (1999)

관련 논문AI추천